Table 2 Subject demographics for patients with type 2 diabetes (n = 51,640) in primary or secondary prevention*.
From: Patterns and predictors of statin prescription in patients with type 2 diabetes
Characteristic | Primary prevention | Secondary prevention | Prevention status unknown |
|---|---|---|---|
Number, (%) | 27,322 (52.9%) | 17,571 (34.0%) | 6,747 (13.1%) |
Male sex (%) | 45.5% | 54.2% | 46.7% |
Age (years) | 62.9 ± 10.9 | 69.3 ± 9.5 | 64.0 ± 10.8 |
Age at diagnosis of diabetes (years) | 57.1 ± 10.9 | 61.0 ± 10.5 | 57.6 ± 11.0 |
Diabetes duration (years) | 5.8 ± 5.7 | 8.3 ± 6.8 | 6.3 ± 5.9 |
Body mass index | 29.1 ± 4.9 | 28.5 ± 4.4 | 29.1 ± 4.8 |
Smoking status (%) | |||
Never smoker | 64.8% | 54.2% | 52.5% |
Former smoker | 17.3% | 27.7% | 17.8% |
Current smoker | 17.6% | 15.0% | 9.0% |
Hypertension (%) | 83.3% | 94.8% | 84.8% |
Microalbuminuria (>20 mg/l) | 27.8% | 34.9% | 31.1% |
HbA1c (%) | |||
<6.5% | 27.3% | 23.8% | 26.1% |
≥6.5% and <7.5% | 37.0% | 34.6% | 35.2% |
≥7.5% and <8.5% | 21.1% | 24.4% | 22.8% |
≥8.5% | 13.9% | 16.3% | 14.5% |
Lipoprotein concentrations (mg/dl) | |||
Total cholesterol | |||
<200 | 27.8% | 32.4% | 30.5% |
≥200 and <240 | 35.4% | 32.0% | 33.2% |
≥240 | 34.7% | 32.2% | 35.0% |
LDL cholesterol | |||
<100 | 12.6% | 16.3% | 14.1% |
≥100 and <130 | 25.0% | 24.2% | 24.1% |
≥130 and <160 | 26.9% | 23.6% | 24.6% |
≥160 | 22.6% | 21.4% | 21.8% |
HDL cholesterol | |||
<40 (M) or <50 (F) | 36.2% | 39.3% | 36.0% |
≥40 (M) or ≥50 (F) | 55.8% | 53.6% | 55.2% |
Triglycerides | |||
<150 | 30.5% | 29.0% | 28.9% |
≥150 and <400 | 50.1% | 51.7% | 50.2% |
≥400 | 4.5% | 4.9% | 3.9% |
On lipid-lowering medication (%) | |||
Any | 24.0% | 45.8% | 31.6% |
Statins | 18.5% | 38.1% | 25.1% |
Fibrates | 5.8% | 7.9% | 7.2% |
Other | 0.11% | 0.14% | 0.10% |
Atherosclerotic risk or disease, respectively | 5-Year atherosclerotic disease risk (%) | Presence of atherosclerotic disease (%) | unknown |
<5%: 11.0% | Coronary heart disease: 78.3% | ||
≥5% and <10%: 21.9% | Cerebrovascular disease: 21.2% | ||
≥10% and <15%: 19.2% | Periph. art. occlussive dis.: 25.7% | ||
≥15% and <20%: 14.0% | |||
≥20% and <25%: 9.3% | |||
≥25% and <30%: 5.7% | |||
≥30%: 8.1% |